Piperaquine Phosphate/Artenimol

磷酸哌喹/双氢青蒿素

Report date: 2026/04/03 20:03:44

Base Information

Drug NamePiperaquine Phosphate/Artenimol
Drug Alias Name双氢青蒿素/磷酸哌喹Dihydroartemisinin/piperaquine phosphate安特新Dihydroartemisinin/Piperaquine TetraphosphateArtenimol/Piperaquine Phosphate +[14
ClassificationSmall molecules
Mechanisms of ActionCytochrome P450 3A4 inhibitors
TargetsCytochrome P450Cytochrome P450 3A4
Therapy Area/IndicationsAnemia, Sickle CellAnemiaHIV Infections +[6
Global Approved IndicationsMalaria, FalciparumMalaria
Approved Indications in ChinaMalaria, Falciparum
Original Approved Country/TerritoryMainland China
Original Approved Date2004/12/07
Country/TerritoryAfghanistanZambiaUganda +[10
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHolleykin
China Registration ClassN/A

Develop Information

Active IndicationsAnemia, Sickle CellMalaria, FalciparumMalaria
Inactive IndicationsAnemiaHIV InfectionsMalaria, Vivax

Other Information

ATC CodeP01BF05
Related LinksWikipedia